Our top pick for
Model N Inc is a software-application business based in the US. Model N shares (MODN) are listed on the NYSE and all prices are listed in US Dollars. Model N employs 781 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$32.29|
|52-week range||$29.92 - $48.20|
|50-day moving average||$34.27|
|200-day moving average||$35.01|
|Wall St. target price||$48.86|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-0.78|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-10-12)||0.22%|
|1 month (2021-09-17)||-9.65%|
|3 months (2021-07-19)||-0.55%|
|6 months (2021-04-19)||-19.46%|
|1 year (2020-10-19)||-10.38%|
|2 years (2019-10-18)||16.36%|
|3 years (2018-10-19)||113.28%|
|5 years (2016-10-19)||216.57%|
Valuing Model N stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Model N's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Model N's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.2045. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Model N's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Model N's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $477,000.
The EBITDA is a measure of a Model N's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$183.4 million|
|Gross profit TTM||$95.6 million|
|Return on assets TTM||-1.72%|
|Return on equity TTM||-22.57%|
|Market capitalisation||$1.2 billion|
TTM: trailing 12 months
There are currently 2.3 million Model N shares held short by investors – that's known as Model N's "short interest". This figure is 3% down from 2.4 million last month.
There are a few different ways that this level of interest in shorting Model N shares can be evaluated.
Model N's "short interest ratio" (SIR) is the quantity of Model N shares currently shorted divided by the average quantity of Model N shares traded daily (recently around 132612.79728199). Model N's SIR currently stands at 17.66. In other words for every 100,000 Model N shares traded daily on the market, roughly 17660 shares are currently held short.
However Model N's short interest can also be evaluated against the total number of Model N shares, or, against the total number of tradable Model N shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Model N's short interest could be expressed as 0.07% of the outstanding shares (for every 100,000 Model N shares in existence, roughly 70 shares are currently held short) or 0.0722% of the tradable shares (for every 100,000 tradable Model N shares, roughly 72 shares are currently held short).
A SIR above 10% would generally be considered pretty high, pointing to a potentially pessimistic outlook for the share price and a discouraging interest in betting against Model N.
Find out more about how you can short Model N stock.
We're not expecting Model N to pay a dividend over the next 12 months.
Over the last 12 months, Model N's shares have ranged in value from as little as $29.92 up to $48.2. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Model N's is 0.9423. This would suggest that Model N's shares are less volatile than average (for this exchange).
Model N, Inc. provides revenue management cloud solutions for the life sciences and high tech industries. The company offers Global Pricing Management, which minimizes price erosion of products; Global Tender Management that enhances revenue by enabling segmentation and targeting, optimal bid pricing, and post-award tracking; Provider Management, which minimizes rebate overpayments; Payer Management that minimizes revenue leakage and noncompliance of complex contracts; Government Pricing, which optimizes revenue, and reduces the risk of fines and other penalties; and Medicaid that enhances compliance with regulatory requirements and payments of rebate claims timely, as well as at correct rates for government medicaid programs. It also provides Deal Management, which increases deal conversion and pricing consistency; Deal Intelligence that controls price concessions and determines ideal prices; Channel Management, which provides manufacturers a view of inventory, as well as evaluate price protection and stock rotation, and matching available inventory to quotes; Market Development Fund Management that allows companies to streamline their MDF process and reduce revenue leakage; and Rebates Management, which centralizes control of rebate programs. In addition, the company offers Channel Data Management that automates the process of collection, cleansing, validation, and standardization of channel partner data, such as POS, inventory, and claims; and Configure Price Quote, which streamlines the quote to contract process by enabling the configuration of complex services, bundles, and solutions into a single interface; and Contract Lifecycle Management that enables users to create and manage contracts directly. Further, it provides implementation, managed, strategic, and customer support services. It primarily serves large and mid-sized organizations worldwide through its direct sales force.
Everything we know about the Aura Biosciences IPO, plus information on how to buy in.
Everything we know about the Claros Mortgage Trust IPO, plus information on how to buy in.
Everything we know about the Evotec SE IPO, plus information on how to buy in.
Everything we know about the Delimobil Holding SA IPO, plus information on how to buy in.
Everything we know about the Blue Water Vaccines IPO, plus information on how to buy in.
Everything we know about the Sonendo IPO, plus information on how to buy in.
Everything we know about the FlexEnergy Green Solutions IPO, plus information on how to buy in.
Everything we know about the Stran & Company IPO, plus information on how to buy in.
Everything we know about the Kidpik Corp IPO, plus information on how to buy in.
Everything we know about the Nuvectis Pharma IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.